Cite
APA Citation
Mark, M., Klingbiel, D., Mey, U., Winterhalder, R., Rothermundt, C., Gillessen, S., von Moos, R., Manetsch, G., & Cathomas, R. (n.d.). 798PImpact of the addition of metformin (Met) to abiraterone (Abi) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) progressing on Abi treatment: A phase II pilot study. Annals of oncology, 28, . http://access.bl.uk/ark:/81055/vdc_100097079636.0x000020